Rare disease drug approval: A second chance worth taking
Rare disease drug approval is back in the spotlight as a once-spurned treatment gets a second chance at regulatory approval.
Health Blog
Rare disease drug approval is back in the spotlight as a once-spurned treatment gets a second chance at regulatory approval.
AstraZeneca Trixeo approval marks a significant advancement in asthma maintenance therapy, offering new hope for patients.